genocea biosciences inc
(GNCA:Consolidated Issue listed on NASDAQ Global Market)
George R. Siber M.D.
Chairman of Scientific Advisory Board and Executive Director, Genocea Biosciences, Inc.
|Age||Total Calculated Compensation||This person is connected to 92 board members in 8 different organizations across 9 different industries.|
See Board Relationships
Dr. George R. Siber, M.D., serves as Chief Scientific Officer of ClearPath Development Company. Dr. Siber served as the Chief Scientific Officer and Executive Vice President of Wyeth Vaccines, Ltd. Dr. Siber oversaw the development and approval of multiple widely-used childhood vaccines including an acellular pertussis vaccine (Acel-Imune), a meningococcal meningitis vaccine (Meningitec), and a pneumococcal vaccine (Prevnar). He served as Associate Professor of Medicine ...
100 Acorn Park DrivePhone: 617-876-8191
Cambridge, Massachusetts 02140
Board Members Memberships*
Director and Member of Scientific Advisory Board
Chairman of Scientific Advisory Board and Executive Director
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Douglas J. Swirsky CPA, CFA||Chief Executive Officer, President, Corporate Secretary and Director|
|Jeffrey D. Abbey MBA, J.D.||Chief Executive Officer, President and Director|
Argos Therapeutics, Inc.
|Eddie Gray||Chief Executive Officer and Director|
Dynavax Technologies Corporation
|Hans Arwidsson Ph.D.||Chief Executive Officer and President|
Eurocine Vaccines AB
|Daniel J. O'Connor Esq.||Chief Executive Officer, President and Director|
|$398.8K||Compensation as of Fiscal Year 2014.|